U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Administrative Destruction of Certain Drugs Refused Admission to the United States (Proposed Rule)
  1. Economic Impact Analyses of FDA Regulations

Administrative Destruction of Certain Drugs Refused Admission to the United States (Proposed Rule)

This rule proposes to implement FDA’s authority to destroy a drug valued at $2,500 or less (or such higher amount as the Secretary of the Treasury may set by regulation) that has been refused admission into the United States under the Federal Food, Drug, and Cosmetic Act (FD&C Act), by providing to the owner or consignee notice and an opportunity to appear and introduce testimony to the Agency prior to the destruction. The proposed regulation is authorized by amendments made to the FD&C Act by the Food and Drug Administration Safety and Innovation Act (FDASIA).  This authority is intended to better protect the public health by providing an administrative process for the destruction of certain refused drugs, thus increasing the integrity of the drug supply chain.

Regulatory Impact Analysis

Administrative Destruction of Certain Drugs Refused Admission to the United States (Proposed Rule) (PDF - 117KB)

   
Back to Top